Cargando…
Identification of a novel CDK9 inhibitor targeting the intramolecular hidden cavity of CDK9 induced by Tat binding
HIV-1 transcription is specifically augmented by a transcriptional activator complex composed of Tat, an HIV-1-encoded activator, and the host transcription elongation factor P-TEFb, which is composed of cyclin-dependent kinase 9 (CDK9) and cyclin T1. Several observations suggest that P-TEFb is an a...
Autores principales: | Asamitsu, Kaori, Hirokawa, Takatsugu, Okamoto, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665388/ https://www.ncbi.nlm.nih.gov/pubmed/36378653 http://dx.doi.org/10.1371/journal.pone.0277024 |
Ejemplares similares
-
MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding
por: Asamitsu, Kaori, et al.
Publicado: (2017) -
Molecular Dynamics Simulation and Experimental Verification of the Interaction between Cyclin T1 and HIV-1 Tat Proteins
por: Asamitsu, Kaori, et al.
Publicado: (2015) -
HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies
por: Asamitsu, Kaori, et al.
Publicado: (2018) -
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016) -
CDK9 inhibitors in acute myeloid leukemia
por: Boffo, Silvia, et al.
Publicado: (2018)